• 1
    Mandema, E., Pollak, V. E., Kark, R. M., and Rezaian, J.: Quantitative observations on antinuclear factors in systemic lupus erythematosus. J. Lab. and Clin. Med., 58: 337, 1961.
  • 2
    Siegel, M., Lee, S. L., Wideleck, D., Reilly, E. B., Wise, G. J., Zingale, S. B., and Fuerst, H. T.: The epidemiology of systemic lupus erythematosus. Preliminary results in New York City. J. Chron. Dis. 15: 131, 1961.
  • 3
    Ansell, B. M., Johnson, G. D., and Weir, D. M.: Antinuclear factors and systemic lupus erythematosus. Lancet. 2: 606, 1961.
  • 4
    Lawrence, J. S.: Prevalence of rheumatoid arthritis. Ann. Rheum. Dis. 20: 11, 1961.
  • 5
    Alexander, W. R. M., and Duthie, J. J. R.: Reaction of lupus erythematosus serum with nuclei of circulating and non-circulating cells. Brit. Med. J. 2: 1565, 1958.
  • 6
    Lee, S. L.: Personal communication.
  • 7
    Beck, J. S.: Variations in the morphological patterns of auto-immune nuclear fluorescence. Lancet 1: 1203, 1961.
  • 8
    Friou, G. J.: Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei. J. Immunol. 80: 476, 1958.
  • 9
    Weir, D. M., Holborow, E. J., and Johnson, G. D.: A clinical study of serum antinuclear factor. Brit. Med. J. 1: 933, 1961.
  • 10
    Goodman, H. C., Fahey, J. L., Malmgren, R. A., and Brecher, G.: Separation of factors in lupus erythematosiis serum reacting with components of cell nuclei. Lancet. 2: 382, 1959.
  • 11
    Baum, J., and Ziff, M.: Reported to Ninth Interim Scientific Session, American Rheumatism Association, Richinond, Va., 1962.
  • 12
    Johnson, G. D., and Holborow, E. J.: Unpublished observations.
  • 13
    Franklin, E. C., and Stanworth, D.: Antigenic relationships between inimune globulins and certain related paraproteins in man. J. Exp. Med. 114: 521, 1961.
  • 14
    Johnson, G. D., and Holborow, E. J.: Immunofluorescent test for infectious mononucleosis. Nature, 198: 1316, 1963.
  • 15
    Marshall, J. D., Eveland, W. C., and Smith, C. W.: Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technique with a modification of its application. Proc. Soc. exp. Biol. & Med. 98: 898, 1958.
  • 16
    Johnson, G. D.: Simplified procedure for removing non-specific staining components from fluorescein-labelled conjugates. Nature 191: 70, 1961.
  • 17
    Chadwick, C. S., and Fothergill, J. E.: In Fluorescent Protein Tracing. Edited by R. C.Nairn. E. and S. Livingstone Ltd., Edinburgh and London, p. 24, 1962.
  • 18
    Smith, C. W., Marshall, J. D., and Eveland, W. C.: Use of contrasting fluorescent dye as counterstain in fixed tissue prepsrations. Proc. Soc. Exp. Biol. (N. Y.) 102: 179 1959.
  • 19
    Hijmans, W., Schmit, H. R. E., Mandema, E., Nienhuis, R. L. F., Feltkamp, T. E. W., Holborow, E. J., and Johnson, G. D.: A comparative study of the detection of antinuclear factors with the Anorescent antibody technique. Presented at Fifth European Congress on Rheumatic Diseases, Stockholm, 1963.
  • 20
    Ansell, B. M., and Lawrence, J. S.: A family study in lupus erythematosus. Arth. & Rheumat. 6: 260, 1963.
  • 21
    Leonhardt, T.: Familial hypergammaglobulinaemia and systemic lupus erythematosus. Lancet 1: 1200, 1957.
  • 22
    Morteo, O. G., Franklin, E. C. M., Ewen, C., Phythyon, J. and Tanner, M.: Studies of relatives of patients with systemic lupus erythematosus. Arth. & Rheumat. 4: 356, 1961.
  • 23
    Ansell, B. M., and Bywaters, E. G. L.: Progress in Still's Disease. Bull. Rheum. Dis. 9: 189, 1959.